High, stable and homogenous CD20 expression for efficient rituximab-induced elimination of CD20+ alloreactive donor T cells in the novel CD20/Rituximab 'suicide' system

被引：1
|
作者：
van Meerten, T [1 ]
Claessen, MJ [1 ]
Hagenbeek, A [1 ]
Ebeling, S [1 ]
机构：
[1] Univ Utrecht, Med Ctr, Jordan Lab Hematooncol, Utrecht, Netherlands
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.1750.1750
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1750
引用
收藏
页码：485A / 485A
页数：1
相关论文
共 50 条
  • [21] Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
    Rouge, Lionel
    Chiang, Nancy
    Steffek, Micah
    Kugel, Christine
    Croll, Tristan I.
    Tam, Christine
    Estevez, Alberto
    Arthur, Christopher P.
    Koth, Christopher M.
    Ciferri, Claudio
    Kraft, Edward
    Payandeh, Jian
    Nakamura, Gerald
    Koerber, James T.
    Rohou, Alexis
    SCIENCE, 2020, 367 (6483) : 1224 - +
  • [22] Reply to Rituximab activity in CD20 positive multiple myeloma
    A Gozzetti
    A Fabbri
    S Lazzi
    M Bocchia
    F Lauria
    Leukemia, 2007, 21 : 1842 - 1843
  • [23] STRUCTURE OF CD20 BOUND TO RITUXIMAB REVEALS MECHANISTIC INFORMATION
    不详
    CANCER DISCOVERY, 2020, 10 (04) : 488 - 488
  • [24] Structural basis for recognition of CD20 by therapeutic antibody rituximab
    Du, Jiamu
    Wang, Hao
    Zhong, Chen
    Peng, Baozhen
    Zhang, Meilan
    Li, Bohua
    Huo, Sheng
    Guo, Yajun
    Ding, Jianping
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (20) : 15073 - 15080
  • [25] Reply to rituximab activity in CD20 positive multiple myeloma
    Gozzetti, A.
    Fabbri, A.
    Lazzi, S.
    Bocchia, M.
    Lauria, F.
    LEUKEMIA, 2007, 21 (08) : 1842 - 1843
  • [26] 抗CD20单克隆抗体—Rituximab
    赵江宁
    朱雅丽
    白血病淋巴瘤., 2004, (02) : 123 - 125
  • [27] Both activating and inhibitory Fc gamma receptors mediate rituximab-induced trogocytosis of CD20 in mice
    Boross, Peter
    Jansen, J. H. Marco
    Pastula, Agnieszka
    van der Poel, Cees E.
    Leusen, Jeanette H. W.
    IMMUNOLOGY LETTERS, 2012, 143 (01) : 44 - 52
  • [28] ALTERED CD20 CONFORMATION AT THE CELL SURFACE OF RITUXIMAB REFRACTORY TUMOR CELLS - A NOVEL MECHANISM OF RITUXIMAB RESISTANCE
    Shimada, K.
    Tomita, A.
    Tokunaga, T.
    Iriyama, C.
    Kinoshita, T.
    Glennie, M.
    Johnson, P.
    Naoe, T.
    ANNALS OF ONCOLOGY, 2011, 22 : 241 - 241
  • [29] Apoptosis of CD20+ tumor cells inducted by Rituximab
    Kotnik, V
    Novakovi, S
    MOLECULAR IMMUNOLOGY, 2006, 43 (1-2) : 183 - 184
  • [30] Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis
    Foran, JM
    Norton, AJ
    Micallef, INM
    Taussig, DC
    Amess, JAL
    Rohatiner, AZS
    Lister, TA
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) : 881 - 883
12345